Home | Jobs |
Fast Answers | Site Map | Search
|
|||||
Comments on NASDAQ RulemakingNotice of Filing of Proposed Rule Change to Modify the Cure Period Available to an Issuer that Loses an Independent Director or Audit Committee Member(Release No. 34-53941; File No. SR-NASDAQ-2006-011)
http://www.sec.gov/comments/sr-nasdaq-2006-011/nasdaq2006011.shtml
|